M, M., D, P., S, G., M, S., D, I., E, K., . . . M, H. (2022). Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. Nature medicine, 28(3), 600. https://doi.org/10.1038/s41591-022-01693-7
Chicago Style (17th ed.) CitationM, Malehmir, et al. "Author Correction: Platelet GPIbα Is a Mediator and Potential Interventional Target for NASH and Subsequent Liver Cancer." Nature Medicine 28, no. 3 (2022): 600. https://doi.org/10.1038/s41591-022-01693-7.
MLA (9th ed.) CitationM, Malehmir, et al. "Author Correction: Platelet GPIbα Is a Mediator and Potential Interventional Target for NASH and Subsequent Liver Cancer." Nature Medicine, vol. 28, no. 3, 2022, p. 600, https://doi.org/10.1038/s41591-022-01693-7.